CA2464634A1 - Pap estimator - Google Patents
Pap estimator Download PDFInfo
- Publication number
- CA2464634A1 CA2464634A1 CA002464634A CA2464634A CA2464634A1 CA 2464634 A1 CA2464634 A1 CA 2464634A1 CA 002464634 A CA002464634 A CA 002464634A CA 2464634 A CA2464634 A CA 2464634A CA 2464634 A1 CA2464634 A1 CA 2464634A1
- Authority
- CA
- Canada
- Prior art keywords
- nsi
- pap
- sensors
- values
- channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/352—Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B7/00—Instruments for auscultation
- A61B7/02—Stethoscopes
- A61B7/04—Electric stethoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
Description
TITLE OF THE INVENTION
PAP ESTIMATOR
BACKGROUND OF THE INVENTION
Pulmonary artery hypertension is caused by several heart or pulmonary diseases including dysfunction of prosthetic or native heart valves, left ventricular dysfunction, congenital abnormalities of the heart and great vessels, chronic obstructive pulmonary disease, and adult respiratory distress syndrome. Pulmonary artery hypertension is a serious cardiovascular dysfunction that is difficult to assess non-invasively. In patients requiring continuous monitoring . or with those suspected with Pulmonary artery hypertension, the Pulmonary Artery Pressure (PAP) is usually measured using a pulmonary arterial catheter. This is an invasive surgical procedure that is associated with significant morbidity and mortality. A pulmonary arterial catheter can be left in place for a few days to allow continuous monitoring of PAP of patients in the critical care unit. However, due to the potential risk to the patients, it is not recommended for repeated measurements that are sometimes necessary (more than 2 days continuous measurements, once per week, once per month or every 6 months depending on the evolution of the disease). Nonetheless, regular evaluation of the PAP is very important to identify pulmonary hypertension and subsequently to follow the evolution of the disease and to assess the efficacy of the treatment. Consequently, non-invasive methods are necessary to allow frequent and accurate measurement of PAP.
Doppler echocardiography is one non-invasive method that can be used to estimate the systolic PAP. if tricuspid regurgitation i s detected, it is possible to estimate the systolic pressure gradient across the tricuspid valve using continuous-wave Doppler. The right ventricular systolic pressure can be calculated by adding the systolic tricuspid valve gradient to the estimated right atrial pressure. The right ventricular systolic pressure can be considered equivalent to the systolic PAP when the systolic pressure gradient across the pulmonary valve is negligible. This noninvasive method can provide a high degree of correlation (0.89 < r < 0.97) and a standard error estimate (SEE) varying from 7 to 12 mmHg with pulmonary artery catheterization (for systolic PAP range: 20-160 mmHg). However, the estimation of PAP by Doppler echocardiography has several important limitations. First, PAP cannot be estimated by Doppler in approximately 50% of patients with normal PAP, 10 to 20 % of patients with elevated PAP, and 34 to 76% of patients with chronic obstructive pulmonary disease because of the absence of tricuspid regurgitation, a weak Doppler signal, or a poor signal-to-noise ratio. To improve the feasibility of the method in some of these patients, it is necessary to use contrast agent enhancement. Second, Doppler echocardiography tends to overestimate PAP in patients with normal PAP and significantly underestimate the PAP in patients with severe pulmonary arterial hypertension.
Another non-invasive PAP estimation method is based on the spectral properties of the P2 component of the second heart sound. The basic ~rincipie supporting this approach is based on Laplace's Law and assumes that the tension of the pulmonary wall is proportional to the corresponding intra-arterial blood pressure. Similar to a stretched drumhead, it is expected that the resonant frequency of the blood column into the pulmonary artery is proportional to the tension in the arterial wall, and thus to the arterial pressure.
Spectral methods have shown a high correlation between spectral features of P2 and the systolic PAP measured by PA catheterization. The two features were the dominant frequency and the quality factor of the spectrum of P2. In patients with prosthetic heart valves it has been demonstrated that systolic PAP
estimated by Doppler echocardiography can be predicted (r = 0.84, SEE = ~ 5 mmHg, P < 0.0001 ) from the spectra! features extracted from S2.
PAP ESTIMATOR
BACKGROUND OF THE INVENTION
Pulmonary artery hypertension is caused by several heart or pulmonary diseases including dysfunction of prosthetic or native heart valves, left ventricular dysfunction, congenital abnormalities of the heart and great vessels, chronic obstructive pulmonary disease, and adult respiratory distress syndrome. Pulmonary artery hypertension is a serious cardiovascular dysfunction that is difficult to assess non-invasively. In patients requiring continuous monitoring . or with those suspected with Pulmonary artery hypertension, the Pulmonary Artery Pressure (PAP) is usually measured using a pulmonary arterial catheter. This is an invasive surgical procedure that is associated with significant morbidity and mortality. A pulmonary arterial catheter can be left in place for a few days to allow continuous monitoring of PAP of patients in the critical care unit. However, due to the potential risk to the patients, it is not recommended for repeated measurements that are sometimes necessary (more than 2 days continuous measurements, once per week, once per month or every 6 months depending on the evolution of the disease). Nonetheless, regular evaluation of the PAP is very important to identify pulmonary hypertension and subsequently to follow the evolution of the disease and to assess the efficacy of the treatment. Consequently, non-invasive methods are necessary to allow frequent and accurate measurement of PAP.
Doppler echocardiography is one non-invasive method that can be used to estimate the systolic PAP. if tricuspid regurgitation i s detected, it is possible to estimate the systolic pressure gradient across the tricuspid valve using continuous-wave Doppler. The right ventricular systolic pressure can be calculated by adding the systolic tricuspid valve gradient to the estimated right atrial pressure. The right ventricular systolic pressure can be considered equivalent to the systolic PAP when the systolic pressure gradient across the pulmonary valve is negligible. This noninvasive method can provide a high degree of correlation (0.89 < r < 0.97) and a standard error estimate (SEE) varying from 7 to 12 mmHg with pulmonary artery catheterization (for systolic PAP range: 20-160 mmHg). However, the estimation of PAP by Doppler echocardiography has several important limitations. First, PAP cannot be estimated by Doppler in approximately 50% of patients with normal PAP, 10 to 20 % of patients with elevated PAP, and 34 to 76% of patients with chronic obstructive pulmonary disease because of the absence of tricuspid regurgitation, a weak Doppler signal, or a poor signal-to-noise ratio. To improve the feasibility of the method in some of these patients, it is necessary to use contrast agent enhancement. Second, Doppler echocardiography tends to overestimate PAP in patients with normal PAP and significantly underestimate the PAP in patients with severe pulmonary arterial hypertension.
Another non-invasive PAP estimation method is based on the spectral properties of the P2 component of the second heart sound. The basic ~rincipie supporting this approach is based on Laplace's Law and assumes that the tension of the pulmonary wall is proportional to the corresponding intra-arterial blood pressure. Similar to a stretched drumhead, it is expected that the resonant frequency of the blood column into the pulmonary artery is proportional to the tension in the arterial wall, and thus to the arterial pressure.
Spectral methods have shown a high correlation between spectral features of P2 and the systolic PAP measured by PA catheterization. The two features were the dominant frequency and the quality factor of the spectrum of P2. In patients with prosthetic heart valves it has been demonstrated that systolic PAP
estimated by Doppler echocardiography can be predicted (r = 0.84, SEE = ~ 5 mmHg, P < 0.0001 ) from the spectra! features extracted from S2.
Another approach for estimating PAP has been proposed in US Patent No.
6,368,28381 using advanced signal processing techniques on S2 heart sounds and incorporated herein by reference. The splitting tirne interval (SI) between the aortic (A2) and the pulmonary (P2) components of S2 is measured using a computer-assisted (but not fully automated) spectral de-chirping method and is normalized for heart rate - Normalized SI (NSI). Here, the idea is that the NSI is proportional to PAP.
BRIEF DESCRIPTION OF THE DRAWINGS
In the appended drawings:
Figure 1 discloses an illustrative embodiment of a PAP estimator according to an illustrative embodiment of the present invention;
Figure 2 discloses typical signals detected using an ECG and a pair of biological sound monitors (BSM1 and BSM 2) )according to an illustrative embodiment of the present invention; and Figures 3A and 3B disclose a flow chart of the A2, P2 and NSI detection portion of the PAP estimator according to an illustrative embodiment of the present invention.
DETAILED DESCRIPTION OF THE ILLUSTRATIVE EMBODIMENTS
Referring now to Figure 1, an illustrative embodiment of a PAP Estimator, generally referred to using the reference numeral 10, will now be described.
Illustratively, two identical biologics! sound sensors 12, for example those described in US Patent No. 6,661,161 are provided for, although in a given application a different number of sensors may be preferable. The sensors 12 are placed at two different locations on the patient 14. One sensor 12~ is positioned at the apex of heart, where the A2 component of the S2 sound is likely at its maximal in intensity and P2 component is minimal. A second sensor 122 is placed to maximize the P2 component intensity (between the 3'd and 4th left intercostal space). The best sensor locations are obtained by experimenting with different positions while observing S2 sound signals, so as to achieve the maxima! signal intensity.
The sensors 12 are attached via appropriate leads as in 16 to a data acquisition system 18 comprised of an analog to digital converter 20 and personal computer 22. Data collected by the sensors 12 is digitised by the analog to digital converter 20, illustratively using a sampling rate of 2k~lz with 12 bits of resolution. Additionally, EEG signals are also collected via a series of electrodes 24, leads 26 and a second analog to digital converter 28. Similar to the acoustic data collected by the biological sound sensors 12, data collected by the EEG electrodes 24 is digitised by the analog to digifial converter 28, illustratively using a sampling rate of 2kHz with 12 bits of resolution. As will be seen below, the electrocardiogram is used as the reference signal to frame the second heart sound (S2).
Referring now to Figure 2, an Electrocardiogram (ECG) reading is displayed along side readings from first and second biological sound sensors.
Automatic A2 and P2 Detection The electrocardiogram is used to provide the reference signal to frame the second heart sound (S2). The beat signal in the description below means the part of acoustic signal between two consecutive QRS complexes on the ECG.
For each beat signal the first heart signal (S1 ) is detected and removed. The remaining sounds, including the second heart sounds and possibly murmurs and the like, are used as input.
6,368,28381 using advanced signal processing techniques on S2 heart sounds and incorporated herein by reference. The splitting tirne interval (SI) between the aortic (A2) and the pulmonary (P2) components of S2 is measured using a computer-assisted (but not fully automated) spectral de-chirping method and is normalized for heart rate - Normalized SI (NSI). Here, the idea is that the NSI is proportional to PAP.
BRIEF DESCRIPTION OF THE DRAWINGS
In the appended drawings:
Figure 1 discloses an illustrative embodiment of a PAP estimator according to an illustrative embodiment of the present invention;
Figure 2 discloses typical signals detected using an ECG and a pair of biological sound monitors (BSM1 and BSM 2) )according to an illustrative embodiment of the present invention; and Figures 3A and 3B disclose a flow chart of the A2, P2 and NSI detection portion of the PAP estimator according to an illustrative embodiment of the present invention.
DETAILED DESCRIPTION OF THE ILLUSTRATIVE EMBODIMENTS
Referring now to Figure 1, an illustrative embodiment of a PAP Estimator, generally referred to using the reference numeral 10, will now be described.
Illustratively, two identical biologics! sound sensors 12, for example those described in US Patent No. 6,661,161 are provided for, although in a given application a different number of sensors may be preferable. The sensors 12 are placed at two different locations on the patient 14. One sensor 12~ is positioned at the apex of heart, where the A2 component of the S2 sound is likely at its maximal in intensity and P2 component is minimal. A second sensor 122 is placed to maximize the P2 component intensity (between the 3'd and 4th left intercostal space). The best sensor locations are obtained by experimenting with different positions while observing S2 sound signals, so as to achieve the maxima! signal intensity.
The sensors 12 are attached via appropriate leads as in 16 to a data acquisition system 18 comprised of an analog to digital converter 20 and personal computer 22. Data collected by the sensors 12 is digitised by the analog to digital converter 20, illustratively using a sampling rate of 2k~lz with 12 bits of resolution. Additionally, EEG signals are also collected via a series of electrodes 24, leads 26 and a second analog to digital converter 28. Similar to the acoustic data collected by the biological sound sensors 12, data collected by the EEG electrodes 24 is digitised by the analog to digifial converter 28, illustratively using a sampling rate of 2kHz with 12 bits of resolution. As will be seen below, the electrocardiogram is used as the reference signal to frame the second heart sound (S2).
Referring now to Figure 2, an Electrocardiogram (ECG) reading is displayed along side readings from first and second biological sound sensors.
Automatic A2 and P2 Detection The electrocardiogram is used to provide the reference signal to frame the second heart sound (S2). The beat signal in the description below means the part of acoustic signal between two consecutive QRS complexes on the ECG.
For each beat signal the first heart signal (S1 ) is detected and removed. The remaining sounds, including the second heart sounds and possibly murmurs and the like, are used as input.
Referring now to the flow charts of Figures 3A and 3B in addition to Figure 1, an illustrative embodiment of an approach for estimating the NSI will now be described. That algorithm supports input signals from the two sensors 12, each of them comprised of signals of heart sounds in the frequency range 30-200 Hz, although this range could be wider without any changes in the approach. If that range is narrower, however, the algorithm shoulld be adapted to those limitations.
Sounds related to heart beats are collected at 100 via a sensor 12 and divided into three sub channels 102, 104 and 106 (or frequency bands). These bands are: Low Frequency (LF, 30-50 Hz), Medium Frequency (MF, 50 -150 Hz), and High Frequency (HF, 120-200 Hz).
Each sub-channel is relayed to a "Process Channel" block as in 108, 1082, and 1083, (these will be described separately hereinbelow). The process channel block can be based on a variety of algorithms including a Chirplet algorithm, Non-linear Energy Operator (NLEO) algorithm, or any other suitable algorithm capable of extracting and discriminating A2 and P2 components from second heart sound S2.
Of note is that the present illustrative embodiment applies the NLEO
algorithm.
The output values of A2 and P2 from the process channel blocks as in 108, 1082, and 1083 are analysed. If both components A2, I'2 are clearly detectable in at least one of the sub channels, these are the values for A2, P2. If both components are not clearly detectable then the outputs of the process channel blocks as in 108, 1082, and 1083 are compared sub-channel by sub-channel with the output of the process channel blocks for other sensors (not shown) of the same sub channels at blocks 110, 112, and 114. In the case at hand, there are illustratively two sensors (the second sensor not shown) the outputs of the process blocks of which are thus compared pair wise.
_6_ Illustratively, the comparison is carried out on each frequency band according to the following set of rules, although it should be understood that this is an example and not intended to be limiting:
~ If the output of 108 for both sensors reveals A2 and P2 components and the positions of A2 and P2 are the same, then these positions provide the values of A2 and P2;
~ If one of the outputs of 108 for both sensors reveals A2 and P2 components, but the other does not, then the positions of these A2 and P2 provide the values of A2 and P2;
~ If the output of 108 for both sensors reveals only one A2 or one P2 component then, as it is unknown whether the component is A2 or P2, then the value of A2 is the position of the first component and the value of P2 the position of the second component.
~ If the output of 108 for one of the sensors rE;veals both A2 and P2 components while the output of 108 for the other sensor reveals only one (A2 or P2) component, then the reading: for both sensors are combined (superimposed).
o If the result reveals only two component, (A2 and P2) then the positions of these A2 and P2 provide the values of A2 and P2;
o If the result still reveals three components (where one or two of the results are A2 andlor P2 and the remainder the result of biological noise), then the readings are combined (superimposed) and the two components with the greateat FWE are selected as A2 and P2, the positions of these A2 and P2 provide the values of A2 and P2.
~ If the output of 108 for both sensors reveals A2 and P2 components but the positions of A2 and P2 are different, then:
o If the Splitting Interval (SI) of both sensor; is less than 10ms then the value of A2 is the position of A2 and the value of P2 is the position of P2 as determined via one of the sensors;
o If at least one of the SI from first or second sensor is greater than 10ms, all components (A2 and P2) within 10 ms are merged.
~ If only one component results, then the value of both A2 and P2 is the position this one component and resulting SI
is equal to zero;
~ If two components result, then the value of A2 is the position of the first component and the value of P2 the position of the second component;
~ If three components result, then the values of A2 and P2 are the positions of the two components with the greatest FWE; and ~ If four components result, then the values of A2 and P2 are the positions of A2 and P2 from the sensor where the amplitude of components FWE is greater than that of the other sensor.
The NSI for each sub-channel, including combined channels, is also calculated.
The A2 and P2 components in the LF, MF, and HF sub-channels have small variation in positioning because of different frequency content. As a result, at block 116, heuristic rules are used to correct those deviations and produce A2 and P2 single values from the combination of A2 and P2 from all sub-channels (LF, MF, HF) as well as any combined values which may have been generated.
An illustrative example of the heuristic rules applied at block 116 is as follows:
~ If no values for both A2 and P2 (from which the NSI is calculated) are available in the MF and HF sub-channels and i:he NSI of the LF channel > 120msec, then discard the NSI of the LF channel;
~ If no values for both A2 and P2 are available in the LF and HF sub-channels and the NSI of the LF channel > 1.4 * NSi of the HF channel, then discard the NSI of the LF channel;
~ If no values for both A2 and P2 are available in the LF and MF sub channels, and the NSI of the LF channel > 1.4 * the NSI of the MF
channel, then the NSI of the LF channel = 1.4 * the NSI of the MF
channel; and ~ If no values for both A2 and P2 are available in the MF and HF sub-channels, and the NSI of the MF channel < 1.4 * the NSI of the HF
channel, then the NSI of the HF channel = (111.4) * the NSI of the MF
channel.
Referring now to Figure 3B, the normalised values of A2, P2 and NSI for the current beat are calculated at blocks 118, 120 and 122 and stored at blocks 124, 126 and 128. Illustratively, values of NA2, NP2 and NSI calculated for beats during the previous minute are retained.
At the same time consistency of solution and signal-to-noise ratio (SNR) for each sub-channel is estimated and stored in separated lists. In this regard, for each sub-range the SNR is estimated. Consistency indicates the percentage of beats not rejected due to high noise. Illustratively, in order to determine the SNR, the S2 sound is first detected as well as the precise position of start and end of S2. The signal component (S) is calculated as the energy between the start and end of S2, divided by the duration of S2 (in cosec). The noise component (N) is calculated as the energy within 50 cosec segment before S2 start added to the energy within 50 cosec segment after S2 end divided by 100 cosec. The resulting signal-to-noise ratio is calculated as SNR = SIN.
After all beats within the time averaging interval {in the case at hand illustratively 1 minute) have been processed in the above manner, a series of values of A2, P2, NSI are ready for statistical validation. At a first step of that validation the laws of distribution of A2 and P2 are estimated and threshold value T calculated using the bias criterion. Typically between 50-200 beats are present during a one minute sampling interval. Histograms are used in order to _g_ provide an estimation of the distribution laws. The distribution law of NSI is used for additional control of the T value in the case of rnulti-peak distribution or A2 or P2.
At block 130, any values of A2 which are greater than T and values of P2 less than T are discarded from the stored values. The NSI values are then recalculated at block 132 using only those A2 and P2 values which still have pairs.
At blocks 134, 136 and 138 the central peaks on A2, P2 and NSI histograms are estimated using two-iteration algorithm. Then at block 140 the value NSI' _ P2-A2 is calculated.
At block 142, NSI' is compared with the peak value of NSI calculated at block 138. If the difference between NSI and NSI' is less than 0.01 (or 1 % in terms of average beat duration), the mean value of NSI and NSI' is produced as the final output value for NSI. If a difference between NSI and NSI' is greater than 0.01, the value of NSI, NSI' with the higher consistency value, as previously calculated at blocks 144, 146 is produced as the final output value.
Referring back to Figure 3A, as stated hereinabove, the process channel block 108 can be based on a variety of algorithms including a Chirplet algorithm, NLEO algorithm, or any other suitable algorithm capable of extracting and discriminating A2 and P2 components from second heart sound S2.
Illustratively, the NLEO algorithm is described and comprises the following processing steps. Referring to block 1082, The Signal to Noise Ratio (SNR) is determined at block 148.
At decision block 150, if the SNR is below a predeternnined value (illustratively 1.5), the current beat is discarded and no further processing steps carried out, giving rise to an empty set of A2, P2 at block 152 (in effect, these values are flagged to indicate that this particular beat is noisy and should not be used for any combinations. Alternatively, if the SNR is above a predetermined value the NLEO function is calculated at block 154 using the current beat's signal.
In this regard, the NLEO function (also known as the Frequency Weighted Energy (FWE) criterion) or any other individual implementation of general family of Autocorrelators can be used.
NLEO is a simple manipulation of digital signal described in the general case by:
'I'~n~=x(n-l)'x~wm)-x~wP)'x~ny) foYl+m=p+q (1) One of NLEO's properties is the ability to compactly describe the notion of frequency-weighted energy (FWE), which is different from the mean-square energy as it reflects both the amplitude as well as the frequency content of a signal. In the case of a pure tone the output can be described as:
F (A*sin (w*n)J = A2*sin (w*(I p+q-s)/2) * sin (w*(q-s-I+p)l2) (2) For the special case where l ~ m and p ~ q, given an input of additive white Gaussian noise (AWGN) the expected value of NLEO output is zero. Thus it has the ability to suppress noise. If we consider the case of amplitude modulated short duration sinusoidal burst in the presence of random noise and structured sinusoidal interference (as in the case of the aortic and the pulmonary components of the S2 sound in the midst of noise), it is anticipated that the NLEO output will enhance FWE of each of these components while suppressing AWGN interference and provide a constant baseline for sinusoidal interference. The time-varying nature of amplitude (Gaussian) and chirping of the dominant rhythm will modulate the NLEO output and produce a detectable burst corresponding to each component in contrast to background clutter. It will then be possible to apply detection strategies on the NLEO output with S2 sound input.
Illustratively, NLEO with parameters I = 2, m = 3, p = 1, q = 4 was applied.
For those parameters the output is:
FjA*sin(w*T)J = A2*sin(wT) * sin(2wT) = 0.5*(cos(wT) - cos(3wT)) (3) Once the NLEO function is calculated, at block 15fi the highest peak (maximum of NLEO output for given beat signal) is determined and those peaks having values of less than 0.05 of highest peak value are removed. In this regard, 0.05 provides good results, although other values may also provide adequate results. If more than two peaks remain, the A2 and P2 candidates are identified at block 158. If only one peak is detected, then this is passed to the output and determined as A2 or P2 according to the procedure described hereinabove at paragraph 18.
Finally, at block 160 the values of A2 and P2 are validated using list of heuristic rules. An illustrative example of such rules are:
~ if time interval between A2 and P2 on NLEO is greater than 100 msec, the component with lower FWE is invalid;
~ if time interval between A2 and P2 on NLEO is less than 10 msec, check for those components on original S2 signal. If there is no separated components, the component with lower FWE is invalid; and ~ if there is difference more then 10 times befinreen FWE of A2 and P2 components, the component with lower FWE is invalidated.
Although the present invention has been described hereinabove by way of an illustrative embodiment thereof, this embodiment can be modified at will, within the scope of the present invention, without departing from the spirit and nature of the subject of the present invention.
Sounds related to heart beats are collected at 100 via a sensor 12 and divided into three sub channels 102, 104 and 106 (or frequency bands). These bands are: Low Frequency (LF, 30-50 Hz), Medium Frequency (MF, 50 -150 Hz), and High Frequency (HF, 120-200 Hz).
Each sub-channel is relayed to a "Process Channel" block as in 108, 1082, and 1083, (these will be described separately hereinbelow). The process channel block can be based on a variety of algorithms including a Chirplet algorithm, Non-linear Energy Operator (NLEO) algorithm, or any other suitable algorithm capable of extracting and discriminating A2 and P2 components from second heart sound S2.
Of note is that the present illustrative embodiment applies the NLEO
algorithm.
The output values of A2 and P2 from the process channel blocks as in 108, 1082, and 1083 are analysed. If both components A2, I'2 are clearly detectable in at least one of the sub channels, these are the values for A2, P2. If both components are not clearly detectable then the outputs of the process channel blocks as in 108, 1082, and 1083 are compared sub-channel by sub-channel with the output of the process channel blocks for other sensors (not shown) of the same sub channels at blocks 110, 112, and 114. In the case at hand, there are illustratively two sensors (the second sensor not shown) the outputs of the process blocks of which are thus compared pair wise.
_6_ Illustratively, the comparison is carried out on each frequency band according to the following set of rules, although it should be understood that this is an example and not intended to be limiting:
~ If the output of 108 for both sensors reveals A2 and P2 components and the positions of A2 and P2 are the same, then these positions provide the values of A2 and P2;
~ If one of the outputs of 108 for both sensors reveals A2 and P2 components, but the other does not, then the positions of these A2 and P2 provide the values of A2 and P2;
~ If the output of 108 for both sensors reveals only one A2 or one P2 component then, as it is unknown whether the component is A2 or P2, then the value of A2 is the position of the first component and the value of P2 the position of the second component.
~ If the output of 108 for one of the sensors rE;veals both A2 and P2 components while the output of 108 for the other sensor reveals only one (A2 or P2) component, then the reading: for both sensors are combined (superimposed).
o If the result reveals only two component, (A2 and P2) then the positions of these A2 and P2 provide the values of A2 and P2;
o If the result still reveals three components (where one or two of the results are A2 andlor P2 and the remainder the result of biological noise), then the readings are combined (superimposed) and the two components with the greateat FWE are selected as A2 and P2, the positions of these A2 and P2 provide the values of A2 and P2.
~ If the output of 108 for both sensors reveals A2 and P2 components but the positions of A2 and P2 are different, then:
o If the Splitting Interval (SI) of both sensor; is less than 10ms then the value of A2 is the position of A2 and the value of P2 is the position of P2 as determined via one of the sensors;
o If at least one of the SI from first or second sensor is greater than 10ms, all components (A2 and P2) within 10 ms are merged.
~ If only one component results, then the value of both A2 and P2 is the position this one component and resulting SI
is equal to zero;
~ If two components result, then the value of A2 is the position of the first component and the value of P2 the position of the second component;
~ If three components result, then the values of A2 and P2 are the positions of the two components with the greatest FWE; and ~ If four components result, then the values of A2 and P2 are the positions of A2 and P2 from the sensor where the amplitude of components FWE is greater than that of the other sensor.
The NSI for each sub-channel, including combined channels, is also calculated.
The A2 and P2 components in the LF, MF, and HF sub-channels have small variation in positioning because of different frequency content. As a result, at block 116, heuristic rules are used to correct those deviations and produce A2 and P2 single values from the combination of A2 and P2 from all sub-channels (LF, MF, HF) as well as any combined values which may have been generated.
An illustrative example of the heuristic rules applied at block 116 is as follows:
~ If no values for both A2 and P2 (from which the NSI is calculated) are available in the MF and HF sub-channels and i:he NSI of the LF channel > 120msec, then discard the NSI of the LF channel;
~ If no values for both A2 and P2 are available in the LF and HF sub-channels and the NSI of the LF channel > 1.4 * NSi of the HF channel, then discard the NSI of the LF channel;
~ If no values for both A2 and P2 are available in the LF and MF sub channels, and the NSI of the LF channel > 1.4 * the NSI of the MF
channel, then the NSI of the LF channel = 1.4 * the NSI of the MF
channel; and ~ If no values for both A2 and P2 are available in the MF and HF sub-channels, and the NSI of the MF channel < 1.4 * the NSI of the HF
channel, then the NSI of the HF channel = (111.4) * the NSI of the MF
channel.
Referring now to Figure 3B, the normalised values of A2, P2 and NSI for the current beat are calculated at blocks 118, 120 and 122 and stored at blocks 124, 126 and 128. Illustratively, values of NA2, NP2 and NSI calculated for beats during the previous minute are retained.
At the same time consistency of solution and signal-to-noise ratio (SNR) for each sub-channel is estimated and stored in separated lists. In this regard, for each sub-range the SNR is estimated. Consistency indicates the percentage of beats not rejected due to high noise. Illustratively, in order to determine the SNR, the S2 sound is first detected as well as the precise position of start and end of S2. The signal component (S) is calculated as the energy between the start and end of S2, divided by the duration of S2 (in cosec). The noise component (N) is calculated as the energy within 50 cosec segment before S2 start added to the energy within 50 cosec segment after S2 end divided by 100 cosec. The resulting signal-to-noise ratio is calculated as SNR = SIN.
After all beats within the time averaging interval {in the case at hand illustratively 1 minute) have been processed in the above manner, a series of values of A2, P2, NSI are ready for statistical validation. At a first step of that validation the laws of distribution of A2 and P2 are estimated and threshold value T calculated using the bias criterion. Typically between 50-200 beats are present during a one minute sampling interval. Histograms are used in order to _g_ provide an estimation of the distribution laws. The distribution law of NSI is used for additional control of the T value in the case of rnulti-peak distribution or A2 or P2.
At block 130, any values of A2 which are greater than T and values of P2 less than T are discarded from the stored values. The NSI values are then recalculated at block 132 using only those A2 and P2 values which still have pairs.
At blocks 134, 136 and 138 the central peaks on A2, P2 and NSI histograms are estimated using two-iteration algorithm. Then at block 140 the value NSI' _ P2-A2 is calculated.
At block 142, NSI' is compared with the peak value of NSI calculated at block 138. If the difference between NSI and NSI' is less than 0.01 (or 1 % in terms of average beat duration), the mean value of NSI and NSI' is produced as the final output value for NSI. If a difference between NSI and NSI' is greater than 0.01, the value of NSI, NSI' with the higher consistency value, as previously calculated at blocks 144, 146 is produced as the final output value.
Referring back to Figure 3A, as stated hereinabove, the process channel block 108 can be based on a variety of algorithms including a Chirplet algorithm, NLEO algorithm, or any other suitable algorithm capable of extracting and discriminating A2 and P2 components from second heart sound S2.
Illustratively, the NLEO algorithm is described and comprises the following processing steps. Referring to block 1082, The Signal to Noise Ratio (SNR) is determined at block 148.
At decision block 150, if the SNR is below a predeternnined value (illustratively 1.5), the current beat is discarded and no further processing steps carried out, giving rise to an empty set of A2, P2 at block 152 (in effect, these values are flagged to indicate that this particular beat is noisy and should not be used for any combinations. Alternatively, if the SNR is above a predetermined value the NLEO function is calculated at block 154 using the current beat's signal.
In this regard, the NLEO function (also known as the Frequency Weighted Energy (FWE) criterion) or any other individual implementation of general family of Autocorrelators can be used.
NLEO is a simple manipulation of digital signal described in the general case by:
'I'~n~=x(n-l)'x~wm)-x~wP)'x~ny) foYl+m=p+q (1) One of NLEO's properties is the ability to compactly describe the notion of frequency-weighted energy (FWE), which is different from the mean-square energy as it reflects both the amplitude as well as the frequency content of a signal. In the case of a pure tone the output can be described as:
F (A*sin (w*n)J = A2*sin (w*(I p+q-s)/2) * sin (w*(q-s-I+p)l2) (2) For the special case where l ~ m and p ~ q, given an input of additive white Gaussian noise (AWGN) the expected value of NLEO output is zero. Thus it has the ability to suppress noise. If we consider the case of amplitude modulated short duration sinusoidal burst in the presence of random noise and structured sinusoidal interference (as in the case of the aortic and the pulmonary components of the S2 sound in the midst of noise), it is anticipated that the NLEO output will enhance FWE of each of these components while suppressing AWGN interference and provide a constant baseline for sinusoidal interference. The time-varying nature of amplitude (Gaussian) and chirping of the dominant rhythm will modulate the NLEO output and produce a detectable burst corresponding to each component in contrast to background clutter. It will then be possible to apply detection strategies on the NLEO output with S2 sound input.
Illustratively, NLEO with parameters I = 2, m = 3, p = 1, q = 4 was applied.
For those parameters the output is:
FjA*sin(w*T)J = A2*sin(wT) * sin(2wT) = 0.5*(cos(wT) - cos(3wT)) (3) Once the NLEO function is calculated, at block 15fi the highest peak (maximum of NLEO output for given beat signal) is determined and those peaks having values of less than 0.05 of highest peak value are removed. In this regard, 0.05 provides good results, although other values may also provide adequate results. If more than two peaks remain, the A2 and P2 candidates are identified at block 158. If only one peak is detected, then this is passed to the output and determined as A2 or P2 according to the procedure described hereinabove at paragraph 18.
Finally, at block 160 the values of A2 and P2 are validated using list of heuristic rules. An illustrative example of such rules are:
~ if time interval between A2 and P2 on NLEO is greater than 100 msec, the component with lower FWE is invalid;
~ if time interval between A2 and P2 on NLEO is less than 10 msec, check for those components on original S2 signal. If there is no separated components, the component with lower FWE is invalid; and ~ if there is difference more then 10 times befinreen FWE of A2 and P2 components, the component with lower FWE is invalidated.
Although the present invention has been described hereinabove by way of an illustrative embodiment thereof, this embodiment can be modified at will, within the scope of the present invention, without departing from the spirit and nature of the subject of the present invention.
Claims (2)
1. A method for estimating the PAP of a patient, the method comprising the steps of:
collecting a series of second heart sounds (S2) from the patient from at least two sensors;
for each of said sensors and said second heart sounds:
filtering said second heart sound into a plurality of frequency bands; and in each of said frequency bands, deriving the aortic component (A2) and pulmonary component (P2) from said filtered heart sound;
wherein if A2 and P2 are not readily detectable in at least one of said frequency bands, A2 and P2 derived for each of said frequency bands are compared with those of the others of said frequency bands and other sensors using an autocorrelator in order to generate a combined value of A2 and P2; and determining a normalised splitting interval (NSI) for A2 and P2 of said series of second heart sounds.
collecting a series of second heart sounds (S2) from the patient from at least two sensors;
for each of said sensors and said second heart sounds:
filtering said second heart sound into a plurality of frequency bands; and in each of said frequency bands, deriving the aortic component (A2) and pulmonary component (P2) from said filtered heart sound;
wherein if A2 and P2 are not readily detectable in at least one of said frequency bands, A2 and P2 derived for each of said frequency bands are compared with those of the others of said frequency bands and other sensors using an autocorrelator in order to generate a combined value of A2 and P2; and determining a normalised splitting interval (NSI) for A2 and P2 of said series of second heart sounds.
2. The method of claim 1, wherein said autocorrelator is NLEO.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002464634A CA2464634A1 (en) | 2004-04-16 | 2004-04-16 | Pap estimator |
EP05734306A EP1744666A1 (en) | 2004-04-16 | 2005-04-15 | Non-invasive measurement of second heart sound components |
JP2007507636A JP2007532207A (en) | 2004-04-16 | 2005-04-15 | Non-invasive measurement method for the second heart sound component |
CA002569730A CA2569730A1 (en) | 2004-04-16 | 2005-04-15 | Non-invasive measurement of second heart sound components |
PCT/CA2005/000568 WO2005099562A1 (en) | 2004-04-16 | 2005-04-15 | Non-invasive measurement of second heart sound components |
US11/578,462 US7909772B2 (en) | 2004-04-16 | 2005-04-15 | Non-invasive measurement of second heart sound components |
US13/053,202 US20120071767A1 (en) | 2004-04-16 | 2011-03-21 | Pulmonary artery pressure estimator |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002464634A CA2464634A1 (en) | 2004-04-16 | 2004-04-16 | Pap estimator |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2464634A1 true CA2464634A1 (en) | 2005-10-16 |
Family
ID=35276856
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002464634A Abandoned CA2464634A1 (en) | 2004-04-16 | 2004-04-16 | Pap estimator |
CA002569730A Abandoned CA2569730A1 (en) | 2004-04-16 | 2005-04-15 | Non-invasive measurement of second heart sound components |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002569730A Abandoned CA2569730A1 (en) | 2004-04-16 | 2005-04-15 | Non-invasive measurement of second heart sound components |
Country Status (5)
Country | Link |
---|---|
US (2) | US7909772B2 (en) |
EP (1) | EP1744666A1 (en) |
JP (1) | JP2007532207A (en) |
CA (2) | CA2464634A1 (en) |
WO (1) | WO2005099562A1 (en) |
Families Citing this family (284)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9702434A (en) | 1991-03-07 | 1998-05-31 | Masimo Corp | Signal processing apparatus. |
US5638818A (en) | 1991-03-21 | 1997-06-17 | Masimo Corporation | Low noise optical probe |
US8019400B2 (en) | 1994-10-07 | 2011-09-13 | Masimo Corporation | Signal processing apparatus |
EP1905352B1 (en) | 1994-10-07 | 2014-07-16 | Masimo Corporation | Signal processing method |
US5758644A (en) | 1995-06-07 | 1998-06-02 | Masimo Corporation | Manual and automatic probe calibration |
US6002952A (en) | 1997-04-14 | 1999-12-14 | Masimo Corporation | Signal processing apparatus and method |
US6229856B1 (en) | 1997-04-14 | 2001-05-08 | Masimo Corporation | Method and apparatus for demodulating signals in a pulse oximetry system |
WO1999062399A1 (en) | 1998-06-03 | 1999-12-09 | Masimo Corporation | Stereo pulse oximeter |
US6721585B1 (en) | 1998-10-15 | 2004-04-13 | Sensidyne, Inc. | Universal modular pulse oximeter probe for use with reusable and disposable patient attachment devices |
US7245953B1 (en) | 1999-04-12 | 2007-07-17 | Masimo Corporation | Reusable pulse oximeter probe and disposable bandage apparatii |
US6463311B1 (en) | 1998-12-30 | 2002-10-08 | Masimo Corporation | Plethysmograph pulse recognition processor |
US6684090B2 (en) | 1999-01-07 | 2004-01-27 | Masimo Corporation | Pulse oximetry data confidence indicator |
US6360114B1 (en) | 1999-03-25 | 2002-03-19 | Masimo Corporation | Pulse oximeter probe-off detector |
US6515273B2 (en) * | 1999-08-26 | 2003-02-04 | Masimo Corporation | System for indicating the expiration of the useful operating life of a pulse oximetry sensor |
US6377829B1 (en) | 1999-12-09 | 2002-04-23 | Masimo Corporation | Resposable pulse oximetry sensor |
DE60139128D1 (en) | 2000-08-18 | 2009-08-13 | Masimo Corp | PULSE OXIMETER WITH TWO OPERATING MODES |
US6850787B2 (en) | 2001-06-29 | 2005-02-01 | Masimo Laboratories, Inc. | Signal component processor |
US6697658B2 (en) | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
US7355512B1 (en) | 2002-01-24 | 2008-04-08 | Masimo Corporation | Parallel alarm processor |
US6850788B2 (en) | 2002-03-25 | 2005-02-01 | Masimo Corporation | Physiological measurement communications adapter |
US6970792B1 (en) | 2002-12-04 | 2005-11-29 | Masimo Laboratories, Inc. | Systems and methods for determining blood oxygen saturation values using complex number encoding |
US7919713B2 (en) * | 2007-04-16 | 2011-04-05 | Masimo Corporation | Low noise oximetry cable including conductive cords |
US6920345B2 (en) | 2003-01-24 | 2005-07-19 | Masimo Corporation | Optical sensor including disposable and reusable elements |
AU2004262509A1 (en) | 2003-04-23 | 2005-02-17 | Medscansonics, Inc. | Apparatus and method for non-invasive diagnosing of coronary artery disease |
US7003338B2 (en) | 2003-07-08 | 2006-02-21 | Masimo Corporation | Method and apparatus for reducing coupling between signals |
US7500950B2 (en) | 2003-07-25 | 2009-03-10 | Masimo Corporation | Multipurpose sensor port |
US7483729B2 (en) | 2003-11-05 | 2009-01-27 | Masimo Corporation | Pulse oximeter access apparatus and method |
US7438683B2 (en) | 2004-03-04 | 2008-10-21 | Masimo Corporation | Application identification sensor |
EP1722676B1 (en) | 2004-03-08 | 2012-12-19 | Masimo Corporation | Physiological parameter system |
CA2464029A1 (en) * | 2004-04-08 | 2005-10-08 | Valery Telfort | Non-invasive ventilation monitor |
US9341565B2 (en) * | 2004-07-07 | 2016-05-17 | Masimo Corporation | Multiple-wavelength physiological monitor |
US7343186B2 (en) | 2004-07-07 | 2008-03-11 | Masimo Laboratories, Inc. | Multi-wavelength physiological monitor |
US7937128B2 (en) | 2004-07-09 | 2011-05-03 | Masimo Corporation | Cyanotic infant sensor |
US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
US7761127B2 (en) | 2005-03-01 | 2010-07-20 | Masimo Laboratories, Inc. | Multiple wavelength sensor substrate |
CA2604653A1 (en) | 2005-04-13 | 2006-10-19 | Glucolight Corporation | Method for data reduction and calibration of an oct-based blood glucose monitor |
US7962188B2 (en) | 2005-10-14 | 2011-06-14 | Masimo Corporation | Robust alarm system |
WO2007064984A2 (en) | 2005-11-29 | 2007-06-07 | Masimo Corporation | Optical sensor including disposable and reusable elements |
JP4904488B2 (en) * | 2006-01-17 | 2012-03-28 | 国立大学法人 長崎大学 | Lung sound diagnostic device |
US8182443B1 (en) | 2006-01-17 | 2012-05-22 | Masimo Corporation | Drug administration controller |
US8219172B2 (en) | 2006-03-17 | 2012-07-10 | Glt Acquisition Corp. | System and method for creating a stable optical interface |
US8920343B2 (en) | 2006-03-23 | 2014-12-30 | Michael Edward Sabatino | Apparatus for acquiring and processing of physiological auditory signals |
US9176141B2 (en) | 2006-05-15 | 2015-11-03 | Cercacor Laboratories, Inc. | Physiological monitor calibration system |
US7941199B2 (en) | 2006-05-15 | 2011-05-10 | Masimo Laboratories, Inc. | Sepsis monitor |
US8998809B2 (en) * | 2006-05-15 | 2015-04-07 | Cercacor Laboratories, Inc. | Systems and methods for calibrating minimally invasive and non-invasive physiological sensor devices |
US8028701B2 (en) | 2006-05-31 | 2011-10-04 | Masimo Corporation | Respiratory monitoring |
US10188348B2 (en) | 2006-06-05 | 2019-01-29 | Masimo Corporation | Parameter upgrade system |
US8457707B2 (en) | 2006-09-20 | 2013-06-04 | Masimo Corporation | Congenital heart disease monitor |
US8840549B2 (en) | 2006-09-22 | 2014-09-23 | Masimo Corporation | Modular patient monitor |
US9161696B2 (en) * | 2006-09-22 | 2015-10-20 | Masimo Corporation | Modular patient monitor |
US9861305B1 (en) | 2006-10-12 | 2018-01-09 | Masimo Corporation | Method and apparatus for calibration to reduce coupling between signals in a measurement system |
US7880626B2 (en) | 2006-10-12 | 2011-02-01 | Masimo Corporation | System and method for monitoring the life of a physiological sensor |
US8265723B1 (en) | 2006-10-12 | 2012-09-11 | Cercacor Laboratories, Inc. | Oximeter probe off indicator defining probe off space |
US8255026B1 (en) | 2006-10-12 | 2012-08-28 | Masimo Corporation, Inc. | Patient monitor capable of monitoring the quality of attached probes and accessories |
US8280473B2 (en) | 2006-10-12 | 2012-10-02 | Masino Corporation, Inc. | Perfusion index smoother |
US9192329B2 (en) | 2006-10-12 | 2015-11-24 | Masimo Corporation | Variable mode pulse indicator |
US8600467B2 (en) | 2006-11-29 | 2013-12-03 | Cercacor Laboratories, Inc. | Optical sensor including disposable and reusable elements |
EP2096994B1 (en) | 2006-12-09 | 2018-10-03 | Masimo Corporation | Plethysmograph variability determination |
US8852094B2 (en) | 2006-12-22 | 2014-10-07 | Masimo Corporation | Physiological parameter system |
US8652060B2 (en) | 2007-01-20 | 2014-02-18 | Masimo Corporation | Perfusion trend indicator |
US20090093687A1 (en) * | 2007-03-08 | 2009-04-09 | Telfort Valery G | Systems and methods for determining a physiological condition using an acoustic monitor |
US8374665B2 (en) | 2007-04-21 | 2013-02-12 | Cercacor Laboratories, Inc. | Tissue profile wellness monitor |
US8764671B2 (en) | 2007-06-28 | 2014-07-01 | Masimo Corporation | Disposable active pulse sensor |
US8048040B2 (en) | 2007-09-13 | 2011-11-01 | Masimo Corporation | Fluid titration system |
US8310336B2 (en) | 2008-10-10 | 2012-11-13 | Masimo Corporation | Systems and methods for storing, analyzing, retrieving and displaying streaming medical data |
JP5296793B2 (en) | 2007-10-12 | 2013-09-25 | マシモ コーポレイション | Connector assembly |
US8768423B2 (en) | 2008-03-04 | 2014-07-01 | Glt Acquisition Corp. | Multispot monitoring for use in optical coherence tomography |
CN101959462B (en) * | 2008-03-04 | 2013-05-22 | 皇家飞利浦电子股份有限公司 | Non invasive analysis of body sounds |
WO2009134724A1 (en) | 2008-05-02 | 2009-11-05 | Masimo Corporation | Monitor configuration system |
US9107625B2 (en) | 2008-05-05 | 2015-08-18 | Masimo Corporation | Pulse oximetry system with electrical decoupling circuitry |
US20100004518A1 (en) | 2008-07-03 | 2010-01-07 | Masimo Laboratories, Inc. | Heat sink for noninvasive medical sensor |
US8203438B2 (en) | 2008-07-29 | 2012-06-19 | Masimo Corporation | Alarm suspend system |
US8630691B2 (en) | 2008-08-04 | 2014-01-14 | Cercacor Laboratories, Inc. | Multi-stream sensor front ends for noninvasive measurement of blood constituents |
US8911377B2 (en) * | 2008-09-15 | 2014-12-16 | Masimo Corporation | Patient monitor including multi-parameter graphical display |
SE532941C2 (en) | 2008-09-15 | 2010-05-18 | Phasein Ab | Gas sampling line for breathing gases |
US8401602B2 (en) | 2008-10-13 | 2013-03-19 | Masimo Corporation | Secondary-emitter sensor position indicator |
US8346330B2 (en) | 2008-10-13 | 2013-01-01 | Masimo Corporation | Reflection-detector sensor position indicator |
US8771204B2 (en) | 2008-12-30 | 2014-07-08 | Masimo Corporation | Acoustic sensor assembly |
US8588880B2 (en) * | 2009-02-16 | 2013-11-19 | Masimo Corporation | Ear sensor |
US10007758B2 (en) | 2009-03-04 | 2018-06-26 | Masimo Corporation | Medical monitoring system |
US9218454B2 (en) | 2009-03-04 | 2015-12-22 | Masimo Corporation | Medical monitoring system |
US10032002B2 (en) | 2009-03-04 | 2018-07-24 | Masimo Corporation | Medical monitoring system |
US9323894B2 (en) | 2011-08-19 | 2016-04-26 | Masimo Corporation | Health care sanitation monitoring system |
US8388353B2 (en) | 2009-03-11 | 2013-03-05 | Cercacor Laboratories, Inc. | Magnetic connector |
US20100234718A1 (en) * | 2009-03-12 | 2010-09-16 | Anand Sampath | Open architecture medical communication system |
WO2010135373A1 (en) | 2009-05-19 | 2010-11-25 | Masimo Corporation | Disposable components for reusable physiological sensor |
US8571619B2 (en) | 2009-05-20 | 2013-10-29 | Masimo Corporation | Hemoglobin display and patient treatment |
US20110040197A1 (en) * | 2009-07-20 | 2011-02-17 | Masimo Corporation | Wireless patient monitoring system |
US20110208015A1 (en) * | 2009-07-20 | 2011-08-25 | Masimo Corporation | Wireless patient monitoring system |
US8471713B2 (en) | 2009-07-24 | 2013-06-25 | Cercacor Laboratories, Inc. | Interference detector for patient monitor |
US20110028806A1 (en) * | 2009-07-29 | 2011-02-03 | Sean Merritt | Reflectance calibration of fluorescence-based glucose measurements |
US20110028809A1 (en) * | 2009-07-29 | 2011-02-03 | Masimo Corporation | Patient monitor ambient display device |
US8473020B2 (en) | 2009-07-29 | 2013-06-25 | Cercacor Laboratories, Inc. | Non-invasive physiological sensor cover |
US20110087081A1 (en) * | 2009-08-03 | 2011-04-14 | Kiani Massi Joe E | Personalized physiological monitor |
US8688183B2 (en) | 2009-09-03 | 2014-04-01 | Ceracor Laboratories, Inc. | Emitter driver for noninvasive patient monitor |
US20110172498A1 (en) * | 2009-09-14 | 2011-07-14 | Olsen Gregory A | Spot check monitor credit system |
US9579039B2 (en) | 2011-01-10 | 2017-02-28 | Masimo Corporation | Non-invasive intravascular volume index monitor |
US20110137297A1 (en) | 2009-09-17 | 2011-06-09 | Kiani Massi Joe E | Pharmacological management system |
WO2011035070A1 (en) | 2009-09-17 | 2011-03-24 | Masimo Laboratories, Inc. | Improving analyte monitoring using one or more accelerometers |
US8571618B1 (en) | 2009-09-28 | 2013-10-29 | Cercacor Laboratories, Inc. | Adaptive calibration system for spectrophotometric measurements |
US20110082711A1 (en) * | 2009-10-06 | 2011-04-07 | Masimo Laboratories, Inc. | Personal digital assistant or organizer for monitoring glucose levels |
WO2011047211A1 (en) | 2009-10-15 | 2011-04-21 | Masimo Corporation | Pulse oximetry system with low noise cable hub |
EP2488106B1 (en) | 2009-10-15 | 2020-07-08 | Masimo Corporation | Acoustic respiratory monitoring sensor having multiple sensing elements |
US9066680B1 (en) | 2009-10-15 | 2015-06-30 | Masimo Corporation | System for determining confidence in respiratory rate measurements |
WO2011047216A2 (en) | 2009-10-15 | 2011-04-21 | Masimo Corporation | Physiological acoustic monitoring system |
US10463340B2 (en) | 2009-10-15 | 2019-11-05 | Masimo Corporation | Acoustic respiratory monitoring systems and methods |
US8790268B2 (en) | 2009-10-15 | 2014-07-29 | Masimo Corporation | Bidirectional physiological information display |
US9848800B1 (en) | 2009-10-16 | 2017-12-26 | Masimo Corporation | Respiratory pause detector |
US9839381B1 (en) | 2009-11-24 | 2017-12-12 | Cercacor Laboratories, Inc. | Physiological measurement system with automatic wavelength adjustment |
DE112010004682T5 (en) | 2009-12-04 | 2013-03-28 | Masimo Corporation | Calibration for multi-level physiological monitors |
US9153112B1 (en) | 2009-12-21 | 2015-10-06 | Masimo Corporation | Modular patient monitor |
DE112011100282T5 (en) * | 2010-01-19 | 2012-11-29 | Masimo Corporation | Wellness assessment system |
DE112011100761T5 (en) | 2010-03-01 | 2013-01-03 | Masimo Corporation | Adaptive alarm system |
WO2011112524A1 (en) | 2010-03-08 | 2011-09-15 | Masimo Corporation | Reprocessing of a physiological sensor |
US9307928B1 (en) | 2010-03-30 | 2016-04-12 | Masimo Corporation | Plethysmographic respiration processor |
JP5531715B2 (en) * | 2010-03-30 | 2014-06-25 | コニカミノルタ株式会社 | Biological information measuring apparatus and method |
US9138180B1 (en) | 2010-05-03 | 2015-09-22 | Masimo Corporation | Sensor adapter cable |
US8712494B1 (en) | 2010-05-03 | 2014-04-29 | Masimo Corporation | Reflective non-invasive sensor |
US8666468B1 (en) | 2010-05-06 | 2014-03-04 | Masimo Corporation | Patient monitor for determining microcirculation state |
US9326712B1 (en) | 2010-06-02 | 2016-05-03 | Masimo Corporation | Opticoustic sensor |
JP5488913B2 (en) * | 2010-07-07 | 2014-05-14 | 学校法人福岡大学 | Central blood pressure measurement device, cardiac load measurement device, central blood pressure measurement method, and cardiac load measurement method |
US8740792B1 (en) | 2010-07-12 | 2014-06-03 | Masimo Corporation | Patient monitor capable of accounting for environmental conditions |
US9408542B1 (en) | 2010-07-22 | 2016-08-09 | Masimo Corporation | Non-invasive blood pressure measurement system |
WO2012027613A1 (en) | 2010-08-26 | 2012-03-01 | Masimo Corporation | Blood pressure measurement system |
US9775545B2 (en) | 2010-09-28 | 2017-10-03 | Masimo Corporation | Magnetic electrical connector for patient monitors |
JP5710767B2 (en) | 2010-09-28 | 2015-04-30 | マシモ コーポレイション | Depth of consciousness monitor including oximeter |
US8753292B2 (en) * | 2010-10-01 | 2014-06-17 | Angiodynamics, Inc. | Method for locating a catheter tip using audio detection |
US9211095B1 (en) | 2010-10-13 | 2015-12-15 | Masimo Corporation | Physiological measurement logic engine |
US8723677B1 (en) | 2010-10-20 | 2014-05-13 | Masimo Corporation | Patient safety system with automatically adjusting bed |
US20120226117A1 (en) | 2010-12-01 | 2012-09-06 | Lamego Marcelo M | Handheld processing device including medical applications for minimally and non invasive glucose measurements |
US8475396B2 (en) | 2011-02-11 | 2013-07-02 | AventuSoft, LLC | Method and system of an acoustic scene analyzer for body sounds |
WO2012109671A1 (en) | 2011-02-13 | 2012-08-16 | Masimo Corporation | Medical characterization system |
US9066666B2 (en) | 2011-02-25 | 2015-06-30 | Cercacor Laboratories, Inc. | Patient monitor for monitoring microcirculation |
US8830449B1 (en) | 2011-04-18 | 2014-09-09 | Cercacor Laboratories, Inc. | Blood analysis system |
US9095316B2 (en) | 2011-04-20 | 2015-08-04 | Masimo Corporation | System for generating alarms based on alarm patterns |
EP2517621A1 (en) | 2011-04-29 | 2012-10-31 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | A radar apparatus for detecting multiple life-signs of a subject, a method and a computer program product |
US9622692B2 (en) | 2011-05-16 | 2017-04-18 | Masimo Corporation | Personal health device |
US9986919B2 (en) | 2011-06-21 | 2018-06-05 | Masimo Corporation | Patient monitoring system |
US9532722B2 (en) | 2011-06-21 | 2017-01-03 | Masimo Corporation | Patient monitoring system |
US9245668B1 (en) | 2011-06-29 | 2016-01-26 | Cercacor Laboratories, Inc. | Low noise cable providing communication between electronic sensor components and patient monitor |
US11439329B2 (en) | 2011-07-13 | 2022-09-13 | Masimo Corporation | Multiple measurement mode in a physiological sensor |
US9192351B1 (en) | 2011-07-22 | 2015-11-24 | Masimo Corporation | Acoustic respiratory monitoring sensor with probe-off detection |
US8755872B1 (en) | 2011-07-28 | 2014-06-17 | Masimo Corporation | Patient monitoring system for indicating an abnormal condition |
US9782077B2 (en) | 2011-08-17 | 2017-10-10 | Masimo Corporation | Modulated physiological sensor |
US9943269B2 (en) | 2011-10-13 | 2018-04-17 | Masimo Corporation | System for displaying medical monitoring data |
US9808188B1 (en) | 2011-10-13 | 2017-11-07 | Masimo Corporation | Robust fractional saturation determination |
EP3603502B1 (en) | 2011-10-13 | 2023-10-04 | Masimo Corporation | Physiological acoustic monitoring system |
WO2013056160A2 (en) | 2011-10-13 | 2013-04-18 | Masimo Corporation | Medical monitoring hub |
US9778079B1 (en) | 2011-10-27 | 2017-10-03 | Masimo Corporation | Physiological monitor gauge panel |
US9445759B1 (en) | 2011-12-22 | 2016-09-20 | Cercacor Laboratories, Inc. | Blood glucose calibration system |
US9392945B2 (en) | 2012-01-04 | 2016-07-19 | Masimo Corporation | Automated CCHD screening and detection |
US11172890B2 (en) | 2012-01-04 | 2021-11-16 | Masimo Corporation | Automated condition screening and detection |
US10307111B2 (en) | 2012-02-09 | 2019-06-04 | Masimo Corporation | Patient position detection system |
US9480435B2 (en) | 2012-02-09 | 2016-11-01 | Masimo Corporation | Configurable patient monitoring system |
US10149616B2 (en) | 2012-02-09 | 2018-12-11 | Masimo Corporation | Wireless patient monitoring device |
US8764674B2 (en) | 2012-03-08 | 2014-07-01 | Medtronic, Inc. | Heart sound monitoring of pulmonary hypertension |
US9195385B2 (en) | 2012-03-25 | 2015-11-24 | Masimo Corporation | Physiological monitor touchscreen interface |
JP6490577B2 (en) | 2012-04-17 | 2019-03-27 | マシモ・コーポレイション | How to operate a pulse oximeter device |
US9521956B2 (en) | 2012-06-05 | 2016-12-20 | 3M Innovative Properties Company | Enhanced auscultatory sensor and analysis for patient diagnosis |
WO2013184965A1 (en) | 2012-06-07 | 2013-12-12 | Masimo Corporation | Depth of consciousness monitor |
US9697928B2 (en) | 2012-08-01 | 2017-07-04 | Masimo Corporation | Automated assembly sensor cable |
US10827961B1 (en) | 2012-08-29 | 2020-11-10 | Masimo Corporation | Physiological measurement calibration |
US9955937B2 (en) | 2012-09-20 | 2018-05-01 | Masimo Corporation | Acoustic patient sensor coupler |
US9877650B2 (en) | 2012-09-20 | 2018-01-30 | Masimo Corporation | Physiological monitor with mobile computing device connectivity |
US9749232B2 (en) | 2012-09-20 | 2017-08-29 | Masimo Corporation | Intelligent medical network edge router |
US9717458B2 (en) | 2012-10-20 | 2017-08-01 | Masimo Corporation | Magnetic-flap optical sensor |
US9560996B2 (en) | 2012-10-30 | 2017-02-07 | Masimo Corporation | Universal medical system |
US9787568B2 (en) | 2012-11-05 | 2017-10-10 | Cercacor Laboratories, Inc. | Physiological test credit method |
US9750461B1 (en) | 2013-01-02 | 2017-09-05 | Masimo Corporation | Acoustic respiratory monitoring sensor with probe-off detection |
US9724025B1 (en) | 2013-01-16 | 2017-08-08 | Masimo Corporation | Active-pulse blood analysis system |
US9750442B2 (en) | 2013-03-09 | 2017-09-05 | Masimo Corporation | Physiological status monitor |
WO2014164139A1 (en) | 2013-03-13 | 2014-10-09 | Masimo Corporation | Systems and methods for monitoring a patient health network |
US10441181B1 (en) | 2013-03-13 | 2019-10-15 | Masimo Corporation | Acoustic pulse and respiration monitoring system |
US9936917B2 (en) | 2013-03-14 | 2018-04-10 | Masimo Laboratories, Inc. | Patient monitor placement indicator |
WO2014158820A1 (en) | 2013-03-14 | 2014-10-02 | Cercacor Laboratories, Inc. | Patient monitor as a minimally invasive glucometer |
US9986952B2 (en) | 2013-03-14 | 2018-06-05 | Masimo Corporation | Heart sound simulator |
US10456038B2 (en) | 2013-03-15 | 2019-10-29 | Cercacor Laboratories, Inc. | Cloud-based physiological monitoring system |
US9891079B2 (en) | 2013-07-17 | 2018-02-13 | Masimo Corporation | Pulser with double-bearing position encoder for non-invasive physiological monitoring |
WO2015020911A2 (en) | 2013-08-05 | 2015-02-12 | Cercacor Laboratories, Inc. | Blood pressure monitor with valve-chamber assembly |
WO2015038683A2 (en) | 2013-09-12 | 2015-03-19 | Cercacor Laboratories, Inc. | Medical device management system |
US10010276B2 (en) | 2013-10-07 | 2018-07-03 | Masimo Corporation | Regional oximetry user interface |
US11147518B1 (en) | 2013-10-07 | 2021-10-19 | Masimo Corporation | Regional oximetry signal processor |
US10828007B1 (en) | 2013-10-11 | 2020-11-10 | Masimo Corporation | Acoustic sensor with attachment portion |
US10832818B2 (en) | 2013-10-11 | 2020-11-10 | Masimo Corporation | Alarm notification system |
US10279247B2 (en) | 2013-12-13 | 2019-05-07 | Masimo Corporation | Avatar-incentive healthcare therapy |
US11259745B2 (en) | 2014-01-28 | 2022-03-01 | Masimo Corporation | Autonomous drug delivery system |
US10086138B1 (en) | 2014-01-28 | 2018-10-02 | Masimo Corporation | Autonomous drug delivery system |
US10532174B2 (en) | 2014-02-21 | 2020-01-14 | Masimo Corporation | Assistive capnography device |
US9924897B1 (en) | 2014-06-12 | 2018-03-27 | Masimo Corporation | Heated reprocessing of physiological sensors |
US10123729B2 (en) | 2014-06-13 | 2018-11-13 | Nanthealth, Inc. | Alarm fatigue management systems and methods |
US10231670B2 (en) | 2014-06-19 | 2019-03-19 | Masimo Corporation | Proximity sensor in pulse oximeter |
US10111591B2 (en) | 2014-08-26 | 2018-10-30 | Nanthealth, Inc. | Real-time monitoring systems and methods in a healthcare environment |
US10231657B2 (en) | 2014-09-04 | 2019-03-19 | Masimo Corporation | Total hemoglobin screening sensor |
US10383520B2 (en) | 2014-09-18 | 2019-08-20 | Masimo Semiconductor, Inc. | Enhanced visible near-infrared photodiode and non-invasive physiological sensor |
WO2016057553A1 (en) | 2014-10-07 | 2016-04-14 | Masimo Corporation | Modular physiological sensors |
KR102575058B1 (en) | 2015-01-23 | 2023-09-05 | 마시모 스웨덴 에이비 | Nasal/Oral Cannula Systems and Manufacturing |
KR102609605B1 (en) | 2015-02-06 | 2023-12-05 | 마시모 코오퍼레이션 | Fold flex circuit for optical probes |
US10568553B2 (en) | 2015-02-06 | 2020-02-25 | Masimo Corporation | Soft boot pulse oximetry sensor |
USD755392S1 (en) | 2015-02-06 | 2016-05-03 | Masimo Corporation | Pulse oximetry sensor |
MX2017010045A (en) | 2015-02-06 | 2018-04-10 | Masimo Corp | Connector assembly with pogo pins for use with medical sensors. |
US10524738B2 (en) | 2015-05-04 | 2020-01-07 | Cercacor Laboratories, Inc. | Noninvasive sensor system with visual infographic display |
WO2016191307A1 (en) | 2015-05-22 | 2016-12-01 | Cercacor Laboratories, Inc. | Non-invasive optical physiological differential pathlength sensor |
US10448871B2 (en) | 2015-07-02 | 2019-10-22 | Masimo Corporation | Advanced pulse oximetry sensor |
EP3334334A1 (en) | 2015-08-11 | 2018-06-20 | Masimo Corporation | Medical monitoring analysis and replay including indicia responsive to light attenuated by body tissue |
AU2016315947B2 (en) | 2015-08-31 | 2021-02-18 | Masimo Corporation | Wireless patient monitoring systems and methods |
US11504066B1 (en) | 2015-09-04 | 2022-11-22 | Cercacor Laboratories, Inc. | Low-noise sensor system |
US11679579B2 (en) | 2015-12-17 | 2023-06-20 | Masimo Corporation | Varnish-coated release liner |
US10993662B2 (en) | 2016-03-04 | 2021-05-04 | Masimo Corporation | Nose sensor |
US10537285B2 (en) | 2016-03-04 | 2020-01-21 | Masimo Corporation | Nose sensor |
US11191484B2 (en) | 2016-04-29 | 2021-12-07 | Masimo Corporation | Optical sensor tape |
US10608817B2 (en) | 2016-07-06 | 2020-03-31 | Masimo Corporation | Secure and zero knowledge data sharing for cloud applications |
US10617302B2 (en) | 2016-07-07 | 2020-04-14 | Masimo Corporation | Wearable pulse oximeter and respiration monitor |
US11020011B2 (en) * | 2016-07-20 | 2021-06-01 | Cardiac Pacemakers, Inc. | Estimate diastolic pressure |
WO2018071715A1 (en) | 2016-10-13 | 2018-04-19 | Masimo Corporation | Systems and methods for patient fall detection |
US11504058B1 (en) | 2016-12-02 | 2022-11-22 | Masimo Corporation | Multi-site noninvasive measurement of a physiological parameter |
US10750984B2 (en) | 2016-12-22 | 2020-08-25 | Cercacor Laboratories, Inc. | Methods and devices for detecting intensity of light with translucent detector |
US10721785B2 (en) | 2017-01-18 | 2020-07-21 | Masimo Corporation | Patient-worn wireless physiological sensor with pairing functionality |
US10388120B2 (en) | 2017-02-24 | 2019-08-20 | Masimo Corporation | Localized projection of audible noises in medical settings |
WO2018156648A1 (en) | 2017-02-24 | 2018-08-30 | Masimo Corporation | Managing dynamic licenses for physiological parameters in a patient monitoring environment |
US10327713B2 (en) | 2017-02-24 | 2019-06-25 | Masimo Corporation | Modular multi-parameter patient monitoring device |
WO2018156804A1 (en) | 2017-02-24 | 2018-08-30 | Masimo Corporation | System for displaying medical monitoring data |
WO2018156809A1 (en) | 2017-02-24 | 2018-08-30 | Masimo Corporation | Augmented reality system for displaying patient data |
US11086609B2 (en) | 2017-02-24 | 2021-08-10 | Masimo Corporation | Medical monitoring hub |
CN110891486A (en) | 2017-03-10 | 2020-03-17 | 梅西莫股份有限公司 | Pneumonia screening instrument |
WO2018194992A1 (en) | 2017-04-18 | 2018-10-25 | Masimo Corporation | Nose sensor |
US10918281B2 (en) | 2017-04-26 | 2021-02-16 | Masimo Corporation | Medical monitoring device having multiple configurations |
USD835283S1 (en) | 2017-04-28 | 2018-12-04 | Masimo Corporation | Medical monitoring device |
USD835284S1 (en) | 2017-04-28 | 2018-12-04 | Masimo Corporation | Medical monitoring device |
USD835282S1 (en) | 2017-04-28 | 2018-12-04 | Masimo Corporation | Medical monitoring device |
EP3614909B1 (en) | 2017-04-28 | 2024-04-03 | Masimo Corporation | Spot check measurement system |
USD835285S1 (en) | 2017-04-28 | 2018-12-04 | Masimo Corporation | Medical monitoring device |
WO2018208616A1 (en) | 2017-05-08 | 2018-11-15 | Masimo Corporation | System for pairing a medical system to a network controller by use of a dongle |
US11026604B2 (en) | 2017-07-13 | 2021-06-08 | Cercacor Laboratories, Inc. | Medical monitoring device for harmonizing physiological measurements |
USD890708S1 (en) | 2017-08-15 | 2020-07-21 | Masimo Corporation | Connector |
USD906970S1 (en) | 2017-08-15 | 2021-01-05 | Masimo Corporation | Connector |
US10637181B2 (en) | 2017-08-15 | 2020-04-28 | Masimo Corporation | Water resistant connector for noninvasive patient monitor |
US11045163B2 (en) | 2017-09-19 | 2021-06-29 | Ausculsciences, Inc. | Method of detecting noise in auscultatory sound signals of a coronary-artery-disease detection system |
WO2019071050A2 (en) | 2017-10-04 | 2019-04-11 | Ausculsciences, Inc. | Auscultatory sound-or-vibration sensor |
EP4039177A1 (en) | 2017-10-19 | 2022-08-10 | Masimo Corporation | Display arrangement for medical monitoring system |
US11284827B2 (en) | 2017-10-21 | 2022-03-29 | Ausculsciences, Inc. | Medical decision support system |
USD925597S1 (en) | 2017-10-31 | 2021-07-20 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
EP3703566B1 (en) | 2017-10-31 | 2023-07-26 | Masimo Corporation | System for displaying oxygen state indications |
US11766198B2 (en) | 2018-02-02 | 2023-09-26 | Cercacor Laboratories, Inc. | Limb-worn patient monitoring device |
WO2019204368A1 (en) | 2018-04-19 | 2019-10-24 | Masimo Corporation | Mobile patient alarm display |
WO2019209915A1 (en) | 2018-04-24 | 2019-10-31 | Cercacor Laboratories, Inc. | Easy insert finger sensor for transmission based spectroscopy sensor |
US11627919B2 (en) | 2018-06-06 | 2023-04-18 | Masimo Corporation | Opioid overdose monitoring |
US10779098B2 (en) | 2018-07-10 | 2020-09-15 | Masimo Corporation | Patient monitor alarm speaker analyzer |
US11872156B2 (en) | 2018-08-22 | 2024-01-16 | Masimo Corporation | Core body temperature measurement |
US11389093B2 (en) | 2018-10-11 | 2022-07-19 | Masimo Corporation | Low noise oximetry cable |
US11406286B2 (en) | 2018-10-11 | 2022-08-09 | Masimo Corporation | Patient monitoring device with improved user interface |
USD999246S1 (en) | 2018-10-11 | 2023-09-19 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
JP7128960B2 (en) | 2018-10-11 | 2022-08-31 | マシモ・コーポレイション | Patient connector assembly with vertical detent |
USD917564S1 (en) | 2018-10-11 | 2021-04-27 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
USD916135S1 (en) | 2018-10-11 | 2021-04-13 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
USD917550S1 (en) | 2018-10-11 | 2021-04-27 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
USD998630S1 (en) | 2018-10-11 | 2023-09-12 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
USD998631S1 (en) | 2018-10-11 | 2023-09-12 | Masimo Corporation | Display screen or portion thereof with a graphical user interface |
AU2019357721A1 (en) | 2018-10-12 | 2021-05-27 | Masimo Corporation | System for transmission of sensor data using dual communication protocol |
US11464410B2 (en) | 2018-10-12 | 2022-10-11 | Masimo Corporation | Medical systems and methods |
USD897098S1 (en) | 2018-10-12 | 2020-09-29 | Masimo Corporation | Card holder set |
US11684296B2 (en) | 2018-12-21 | 2023-06-27 | Cercacor Laboratories, Inc. | Noninvasive physiological sensor |
US11701043B2 (en) | 2019-04-17 | 2023-07-18 | Masimo Corporation | Blood pressure monitor attachment assembly |
USD919094S1 (en) | 2019-08-16 | 2021-05-11 | Masimo Corporation | Blood pressure device |
USD921202S1 (en) | 2019-08-16 | 2021-06-01 | Masimo Corporation | Holder for a blood pressure device |
USD919100S1 (en) | 2019-08-16 | 2021-05-11 | Masimo Corporation | Holder for a patient monitor |
USD917704S1 (en) | 2019-08-16 | 2021-04-27 | Masimo Corporation | Patient monitor |
USD985498S1 (en) | 2019-08-16 | 2023-05-09 | Masimo Corporation | Connector |
US11832940B2 (en) | 2019-08-27 | 2023-12-05 | Cercacor Laboratories, Inc. | Non-invasive medical monitoring device for blood analyte measurements |
USD927699S1 (en) | 2019-10-18 | 2021-08-10 | Masimo Corporation | Electrode pad |
KR20220083771A (en) | 2019-10-18 | 2022-06-20 | 마시모 코오퍼레이션 | Display layouts and interactive objects for patient monitoring |
CA3157995A1 (en) | 2019-10-25 | 2021-04-29 | Cercacor Laboratories, Inc. | Indicator compounds, devices comprising indicator compounds, and methods of making and using the same |
EP4104037A1 (en) | 2020-02-13 | 2022-12-21 | Masimo Corporation | System and method for monitoring clinical activities |
US11879960B2 (en) | 2020-02-13 | 2024-01-23 | Masimo Corporation | System and method for monitoring clinical activities |
US20210290177A1 (en) | 2020-03-20 | 2021-09-23 | Masimo Corporation | Wearable device for monitoring health status |
USD933232S1 (en) | 2020-05-11 | 2021-10-12 | Masimo Corporation | Blood pressure monitor |
USD979516S1 (en) | 2020-05-11 | 2023-02-28 | Masimo Corporation | Connector |
USD980091S1 (en) | 2020-07-27 | 2023-03-07 | Masimo Corporation | Wearable temperature measurement device |
USD974193S1 (en) | 2020-07-27 | 2023-01-03 | Masimo Corporation | Wearable temperature measurement device |
USD946596S1 (en) | 2020-09-30 | 2022-03-22 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
USD946597S1 (en) | 2020-09-30 | 2022-03-22 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
USD946598S1 (en) | 2020-09-30 | 2022-03-22 | Masimo Corporation | Display screen or portion thereof with graphical user interface |
USD997365S1 (en) | 2021-06-24 | 2023-08-29 | Masimo Corporation | Physiological nose sensor |
USD1000975S1 (en) | 2021-09-22 | 2023-10-10 | Masimo Corporation | Wearable temperature measurement device |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0850014B1 (en) * | 1995-08-10 | 2003-04-16 | Pentavox Kft. | Apparatus for measuring fetal heart rate |
US6050950A (en) | 1996-12-18 | 2000-04-18 | Aurora Holdings, Llc | Passive/non-invasive systemic and pulmonary blood pressure measurement |
US6368283B1 (en) * | 2000-09-08 | 2002-04-09 | Institut De Recherches Cliniques De Montreal | Method and apparatus for estimating systolic and mean pulmonary artery pressures of a patient |
US7689283B1 (en) * | 2004-11-15 | 2010-03-30 | Pacesetter, Inc. | Diastolic mechanical algorithm for optimization of AV timing using a plurality of sensors |
-
2004
- 2004-04-16 CA CA002464634A patent/CA2464634A1/en not_active Abandoned
-
2005
- 2005-04-15 US US11/578,462 patent/US7909772B2/en active Active
- 2005-04-15 WO PCT/CA2005/000568 patent/WO2005099562A1/en active Application Filing
- 2005-04-15 CA CA002569730A patent/CA2569730A1/en not_active Abandoned
- 2005-04-15 JP JP2007507636A patent/JP2007532207A/en not_active Withdrawn
- 2005-04-15 EP EP05734306A patent/EP1744666A1/en not_active Withdrawn
-
2011
- 2011-03-21 US US13/053,202 patent/US20120071767A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1744666A1 (en) | 2007-01-24 |
US7909772B2 (en) | 2011-03-22 |
US20120071767A1 (en) | 2012-03-22 |
JP2007532207A (en) | 2007-11-15 |
CA2569730A1 (en) | 2005-10-27 |
WO2005099562B1 (en) | 2006-03-16 |
WO2005099562A1 (en) | 2005-10-27 |
US20080091115A1 (en) | 2008-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2464634A1 (en) | Pap estimator | |
EP3117766B1 (en) | Processing biological data | |
US8983800B2 (en) | Selection of preset filter parameters based on signal quality | |
US6702752B2 (en) | Monitoring respiration based on plethysmographic heart rate signal | |
US6805673B2 (en) | Monitoring mayer wave effects based on a photoplethysmographic signal | |
US6120459A (en) | Method and device for arterial blood pressure measurement | |
EP1740091B1 (en) | Method and apparatus for optical detection of mixed venous and arterial blood pulsation in tissue | |
KR101210828B1 (en) | Apparatus and method improving accuracy of wrist blood pressure by using multiple bio-signal | |
US7775987B2 (en) | Computation of blood pressure using different signal processing channels | |
US8556821B2 (en) | Adaptive frequency domain filtering for improved non-invasive blood pressure estimation | |
US20050004477A1 (en) | Method and apparatus for measuring blood pressure using relaxed matching criteria | |
DE69734288D1 (en) | BLOODY DETERMINATION OF BLOOD PRESSURE WITHOUT USE OF MANCHETTE | |
JP2007527772A (en) | Selection of ensemble average weights for pulse oximeters based on signal quality metrics | |
US20110270059A1 (en) | Signal processing for pulse oximetry | |
US8202225B2 (en) | Noninvasive method and apparatus for measuring blood pressure by determining a maximum frequency of spectral content of the second heart sound | |
JP2023515256A (en) | Systems and methods for measuring venous oxygen saturation using intelligent pulse averaging with integrated EKG and PPG sensors | |
JP3631639B2 (en) | Blood pressure measurement method | |
WO2017044870A1 (en) | Sensor for ventricular and outflow tract obstruction | |
Naufal et al. | Blood Pressure Measuring Device Based on Korotkoff Sound's Tapping Period and Frequency Detection | |
Pielmus et al. | Progressive dynamic time warping for noninvasive blood pressure estimation | |
US20220361798A1 (en) | Multi sensor and method | |
Korhonen et al. | Estimation of frequency shift in cardiovascular variability signals | |
Sterlin et al. | Methods for increasing reliability and noise protection of arterial pressure measurement channel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |